TeleRehabilitation for Patients With Chronic Respiratory Failure. (e-mouv)

November 21, 2023 updated by: SOS Oxygene Mediterranee

Clinical Benefits of TeleRehabilitation in Chronic Respiratory Failure Patients.

It is widely described in the literature that exercise training improves patients' exercise tolerance, quality of life, symptoms, anxiety and depression, regardless of the location. Despite overwhelming evidence of the benefits of exercise training, only a very small percentage of eligible people have ever completed a program. Alternative modes of exercise training are needed to improve equity of access for patients with chronic respiratory disease. So TeleRehabilitation, using information and communication technologies to provide distance exercise training services, may be an answer.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

220

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • France
      • Cornebarrieu, France, 31700
        • Recruiting
        • Cabinet de pneumologie Clinique des Cèdres
        • Contact:
        • Principal Investigator:
          • Daniel Bajon, MD
        • Principal Investigator:
          • Odile Sizaret, MD
        • Principal Investigator:
          • Sylvain Droneau, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

patients from medical consultation

Description

Inclusion Criteria:

  • chronic respiratory disease patients
  • Patients with dyspnea or exercise intolerance.
  • Stable patients at home.
  • Patients who can use a computer (after explanations) and have adequate hearing and vision.
  • Collection of the patient's non-objection

Exclusion Criteria:

  • Life expectancy <3 months.
  • Absolute contraindication to performing physical activity
  • Hospitalization for exacerbation in the two months prior to inclusion.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Control Group
Chronic respiratory patients who undergo a home-based exercise training program with a rehabilitation coach supervision.
Tele Group
Chronic respiratory patients who undergo a home-based exercise training program online.
Other: telerehabilitation
Patients undergo an online exercise training program via a certified host of health data website.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
exercise tolerance
Time Frame: 3 month after inclusion
number of steps during 6 minute stepper test
3 month after inclusion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
exercise tolerance
Time Frame: 6 month and one year after inclusion
number of steps during 6 minute stepper test
6 month and one year after inclusion
VQ-11
Time Frame: 3, 6 month and 1 year after inclusion
questionnaire, Minimum = 11, maximum = 55; higher score means worth outcome
3, 6 month and 1 year after inclusion
physical activity quantity
Time Frame: 3, 6 month and 1 year after inclusion
questioning patients on their physical activity quantity
3, 6 month and 1 year after inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

SOS Oxygene Mediterranee

Investigators

  • Principal Investigator: william Heurtaux, MD, Clinique des Cèdres

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2020

Primary Completion (Estimated)

September 1, 2025

Study Completion (Estimated)

September 1, 2025

Study Registration Dates

First Submitted

September 22, 2020

First Submitted That Met QC Criteria

September 22, 2020

First Posted (Actual)

September 28, 2020

Study Record Updates

Last Update Posted (Actual)

November 28, 2023

Last Update Submitted That Met QC Criteria

November 21, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2019-102868-49

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exercise

Clinical Trials on telerehabilitation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe